$1.06—Stale · unknown old
NASDAQ • Last print unknown ago
$1.06—Stale · unknown old
Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder
Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model
Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
Results from Phase 1 Multiple-Dose Study of PT00114
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split
Protagenic Therapeutics Shares Increase Over 10% Pre-Market: Why It Happened
Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End
PTIX Stock Price: Over 25% Increase Pre-Market Explanation
Best Biotech Penny Stocks in June 2021? Check These 4 Out
4 Biotech Penny Stocks That You Need to Know About
PTIX Stock: Over 80% Increase Intraday Explanation